[go: up one dir, main page]

FI952972L - Uudet D-vitamiinianalogit - Google Patents

Uudet D-vitamiinianalogit Download PDF

Info

Publication number
FI952972L
FI952972L FI952972A FI952972A FI952972L FI 952972 L FI952972 L FI 952972L FI 952972 A FI952972 A FI 952972A FI 952972 A FI952972 A FI 952972A FI 952972 L FI952972 L FI 952972L
Authority
FI
Finland
Prior art keywords
analogues
new vitamin
vitamin
new
Prior art date
Application number
FI952972A
Other languages
English (en)
Swedish (sv)
Other versions
FI952972A0 (fi
FI108225B (fi
Inventor
Gunnar Grue-Soerensen
Erik Rytter Ottosen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Publication of FI952972A0 publication Critical patent/FI952972A0/fi
Publication of FI952972L publication Critical patent/FI952972L/fi
Application granted granted Critical
Publication of FI108225B publication Critical patent/FI108225B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI952972A 1992-12-23 1995-06-16 Menetelmä uusien D-vitamiinianalogien valmistamiseksi FI108225B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9226877 1992-12-23
GB929226877A GB9226877D0 (en) 1992-12-23 1992-12-23 Chemical compounds
PCT/DK1993/000425 WO1994014766A1 (en) 1992-12-23 1993-12-17 Novel vitamin d analogues
DK9300425 1993-12-17

Publications (3)

Publication Number Publication Date
FI952972A0 FI952972A0 (fi) 1995-06-16
FI952972L true FI952972L (fi) 1995-06-16
FI108225B FI108225B (fi) 2001-12-14

Family

ID=10727157

Family Applications (1)

Application Number Title Priority Date Filing Date
FI952972A FI108225B (fi) 1992-12-23 1995-06-16 Menetelmä uusien D-vitamiinianalogien valmistamiseksi

Country Status (15)

Country Link
US (1) US5554599A (fi)
EP (1) EP0675878B1 (fi)
KR (1) KR100295977B1 (fi)
AT (1) ATE148454T1 (fi)
AU (1) AU668638B2 (fi)
CA (1) CA2146775C (fi)
DE (1) DE69307929T2 (fi)
DK (1) DK0675878T3 (fi)
ES (1) ES2098123T3 (fi)
FI (1) FI108225B (fi)
GB (1) GB9226877D0 (fi)
GR (1) GR3022774T3 (fi)
NZ (1) NZ259317A (fi)
RU (1) RU2136660C1 (fi)
WO (1) WO1994014766A1 (fi)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830885A (en) * 1992-03-12 1998-11-03 The Johns Hopkins University Antiproliferative vitamin D3 hybrids
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US20040167106A1 (en) * 1993-06-04 2004-08-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of a Vitamin D compound
GB9314400D0 (en) * 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
ES2150560T3 (es) * 1994-04-11 2000-12-01 Chugai Pharmaceutical Co Ltd Derivado de la 22-tiavitamina d3.
AU1152997A (en) 1995-12-28 1997-07-28 Chugai Seiyaku Kabushiki Kaisha Malignant tumor metastasis inhibitors
US6869940B2 (en) 1995-12-28 2005-03-22 Chugai Seiyaku Kabushiki Kaisha Malignant tumor metastasis inhibitors
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6184398B1 (en) 1996-12-20 2001-02-06 Chugai Seiyaku Kabushiki Kaisha 16-ene-vitamin D derivatives
KR100573234B1 (ko) * 1996-12-20 2006-04-24 쥬가이 세이야쿠 가부시키가이샤 16-엔-비타민 d 유도체
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
CA2366586C (en) 1999-04-01 2004-06-22 Johns Hopkins University Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1.alpha., 25-dihydroxy vitamin d3
WO2001022974A1 (en) 1999-09-29 2001-04-05 Colotech A/S Prevention of colorectal cancer
US6703380B2 (en) 1999-09-29 2004-03-09 Colotech A/S Prevention of cancer
WO2001030751A2 (en) * 1999-10-25 2001-05-03 Strakan Limited USES OF 1,25-DIHYDROXY-5,6-trans VITAMIN D COMPOUNDS AND DERIVATIVES THEREOF
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US7074777B2 (en) 2000-04-19 2006-07-11 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivatives
US7985744B2 (en) * 2000-06-15 2011-07-26 Chugai Seiyaku Kabushiki Kaisha Vitamin D derivatives
ATE428692T1 (de) * 2001-08-22 2009-05-15 Univ Johns Hopkins 24-schwefel-substituierte 1-alpha-25-dihydroxy- vitamin-d3-analogen
ES2266564T3 (es) 2001-10-19 2007-03-01 Isotechnika Inc. Sintesis de analogos de cicloporinas.
CA2488334C (en) 2002-06-13 2010-12-07 Johns Hopkins University 24-sulfoximine vitamin d3 compounds
CA2510228C (en) 2002-12-18 2012-10-30 Johns Hopkins University 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
CN102341110B (zh) 2009-01-27 2017-04-12 博格有限责任公司 用于减轻与化疗有关的副作用的维生素d3及其类似物
CN105663146B (zh) 2009-08-14 2020-09-11 博格有限责任公司 用于治疗脱发的维生素d3及其类似物
SG11201509715UA (en) 2013-05-29 2015-12-30 Berg Llc Preventing or mitigating chemotherapy induced alopecia using vitamin d

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4749710A (en) * 1985-05-01 1988-06-07 Hoffmann-La Roche Inc. Immunosuppressive agents
SU1445729A1 (ru) * 1986-04-08 1988-12-23 Харьковский научно-исследовательский институт дерматологии и венерологии Способ лечени псориаза
FR2631025B1 (fr) * 1988-05-04 1991-04-12 Ire Medgenix Sa Nouveaux derives de la vitamine d3 et application aux dosages des metabolites de la vitamine d3
GB8904153D0 (en) * 1989-02-23 1989-04-05 Leo Pharm Prod Ltd Chemical compounds
ES2150560T3 (es) * 1994-04-11 2000-12-01 Chugai Pharmaceutical Co Ltd Derivado de la 22-tiavitamina d3.

Also Published As

Publication number Publication date
KR950703501A (ko) 1995-09-20
FI952972A0 (fi) 1995-06-16
AU5808794A (en) 1994-07-19
GB9226877D0 (en) 1993-02-17
DE69307929D1 (de) 1997-03-13
AU668638B2 (en) 1996-05-09
CA2146775A1 (en) 1994-07-07
EP0675878A1 (en) 1995-10-11
RU95113480A (ru) 1997-03-20
NZ259317A (en) 1997-05-26
FI108225B (fi) 2001-12-14
RU2136660C1 (ru) 1999-09-10
DK0675878T3 (da) 1997-04-28
ATE148454T1 (de) 1997-02-15
WO1994014766A1 (en) 1994-07-07
ES2098123T3 (es) 1997-04-16
CA2146775C (en) 2005-06-28
EP0675878B1 (en) 1997-01-29
US5554599A (en) 1996-09-10
GR3022774T3 (en) 1997-06-30
KR100295977B1 (ko) 2001-11-14
DE69307929T2 (de) 1997-09-04

Similar Documents

Publication Publication Date Title
FI950023L (fi) Uudet D-vitamiinianalogit
FI952972L (fi) Uudet D-vitamiinianalogit
FI943099A7 (fi) Uudet D-vitamiinianalogit
FI960303L (fi) D-vitamiinianalogeja
FI935058L (fi) Foer antitumoerbehandling avsedda rekombinant-adenovirus som uttrycker cytokiner
FI931229L (fi) Som glanspigment laempade blandningar
FI934750A7 (fi) Kommunikationsfoerfarande i TDMA-cellulaermobilradiosystem som anvaender frekvenshoppning
FI932052L (fi) Fenylsulfonamidendotelinantagonister
FI925547L (fi) Nya vitamin d analoger
PT90226A (pt) Pulverizador
FI931968L (fi) Foerbaettringar i radiostaempling
FI951968A7 (fi) Uudet D-vitamiinianalogit
FI931069L (fi) Kolloidalt rostat kaffe som aromatiseringsprodukt
FI945811A7 (fi) Des-Tyr-dynorfiinianalogeja
FI956108A7 (fi) Uudet D-vitamiinianalogit
FI933560A7 (fi) Radiotelefonsystem som anvaender en flerabonnentenhet
FI931711A0 (fi) Stoedfot foer kran i kompositmaterial
FI951447L (fi) Uudet D-vitamiinianalogit
FI934751A0 (fi) Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner
FI935092A7 (fi) D3-vitamiinianalogeja
FI951422A7 (fi) Uudet D-vitamiinianalogit
FI923978L (fi) Effektekonomi i mobilteleapparat
FI923709L (fi) I en saekerhetsskena laosbar vagn
FI931058A0 (fi) Rakelbalk foer faergningsanordningen i en tryckmaskin
FI932284L (fi) Kalciumkanaler blockerande polypeptider som haerstammar fraon filistata hibernalis